{{Rsnum
|rsid=41997
|Chromosome=7
|position=118351841
|Orientation=plus
|GMAF=0.275
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 38.0 | 52.8 | 9.3
| HCB | 51.5 | 35.1 | 13.4
| JPT | 63.6 | 31.8 | 4.5
| YRI | 81.7 | 16.9 | 1.4
| ASW | 75.4 | 22.8 | 1.8
| CHB | 51.5 | 35.1 | 13.4
| CHD | 53.3 | 41.1 | 5.6
| GIH | 0.0 | 0.0 | 0.0
| LWK | 67.0 | 27.5 | 5.5
| MEX | 0.0 | 0.0 | 0.0
| MKK | 58.1 | 34.8 | 7.1
| TSI | 35.0 | 49.0 | 16.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22872573
  |Trait=Response to platinum-based chemotherapy in non-small-cell lung cancer
  |Title=Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy.
  |RiskAllele=A
  |Pval=4E-7
  |OR=1.52
  |ORtxt=[1.28-1.79]
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}